Crispr Therapeutics shares owned by ProShare Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by ProShare Advisors
from 13F filings
Historical chart of ProShare Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by ProShare Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 18k | 64.81 |
| 2025-06-30 | $1.0M | 21k | 48.64 |
| 2024-09-30 | $252k | 5.4k | 46.98 |
| 2024-06-30 | $301k | 5.6k | 54.01 |
| 2024-03-31 | $395k | 5.8k | 68.16 |
| 2023-09-30 | $242k | 5.3k | 45.39 |
| 2023-06-30 | $295k | 5.3k | 56.14 |
| 2023-03-31 | $263k | 5.8k | 45.23 |
| 2022-12-31 | $312k | 7.7k | 40.65 |
| 2022-09-30 | $510k | 7.8k | 65.35 |
| 2022-06-30 | $437k | 7.2k | 60.75 |
| 2022-03-31 | $602k | 9.6k | 62.81 |
| 2021-12-31 | $817k | 11k | 75.82 |
| 2021-09-30 | $1.8M | 16k | 111.93 |
| 2021-06-30 | $2.2M | 14k | 161.89 |
| 2021-03-31 | $1.3M | 10k | 121.88 |
| 2020-12-31 | $1.7M | 11k | 153.08 |
| 2020-09-30 | $946k | 11k | 83.66 |
| 2020-06-30 | $717k | 9.8k | 73.53 |
| 2020-03-31 | $348k | 8.2k | 42.46 |
| 2019-12-31 | $783k | 13k | 60.91 |
| 2019-09-30 | $607k | 15k | 41.02 |
| 2019-06-30 | $727k | 15k | 47.08 |
| 2019-03-31 | $634k | 18k | 35.70 |
| 2018-12-31 | $505k | 18k | 28.59 |
| 2018-09-30 | $861k | 19k | 44.37 |
| 2018-06-30 | $1.2M | 20k | 58.75 |
| 2018-03-31 | $973k | 21k | 45.73 |
| 2017-12-31 | $519k | 22k | 23.48 |